Real-World Visual and Neovascularisation Outcomes from anti-VEGF in Central Retinal Vein Occlusion.
Henry David Jeffry HoggJames Stephen TalksMark S PearceSandro Di SimplicioPublished in: Ophthalmic epidemiology (2020)
Visual acuity in CRVO complicated by macular oedema improves following anti-VEGF treatment but real-world gains are more modest than those from clinical trials. Neovascularisation following CRVO can be substantially delayed by anti-VEGF treatment and so if individuals who have received IVIs are to be effectively screened for neovascularisation long-term surveillance is necessary.